phentermine prescription drug
National Retailers Association CEO Patrick McKendry blamed concern over phentermine prescription drug rates. "You had an phentermine prescription drug rate increase in August, but you also had widespread speculation about a further increase in November," he said. "I think that dampened consumer willingness to spend. "And I think that has a sharper and quicker impact in Queensland and WA, where people take on additional debt in the boom and you have much more sensitivity to phentermine prescription drug rates." Nationally consumer spending crept up slightly in October towards the $20 billion mark, seasonally adjusted. But Mr McKendry dismissed that milestone as well below expectations. "We've been hovering around that figure for a long time," he said. "It's not showing much growth. You strip out CPI and there's virtually no growth at all." With last month's phentermine prescription drug rate rise, Mr McKendry said retailers were expecting continued tough trading conditions in November, prompting concerns ahead of the vital Christmas period. "The (interest rate) adjustment in November is starting to bite," he said. But the Queensland Retail Traders and Shopkeepers Association took a more optimistic view, arguing the October retail figures were an aberration and predicting spending would soon pick up. Spokesman Scott Driscoll said the Queensland retail scene was divided, with luxury products selling well but a downturn at the lower end of the market. Other ABS figures released yesterday revealed Australia's population had topped 21 million by July this year. The population increase for the year, 315,700, was the highest ever recorded, as was the birth rate of 272,900 babies. Share this article What is this? ... phentermine prescription drug